During the past decade, Hospital Arnau de Vilanova conducted 48 clinical trials. In the 10-year time frame, 48 clinical trials started and 17 clinical trials were completed, i.e. on average, 35.4% percent of trials that started reached the finish line to date. In the past 5 years, 24 clinical trials started and 11 clinical trials were completed. i.e. 45.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Arnau de Vilanova" #1 sponsor was "MedSIR" with 10 trials, followed by "PETHEMA Foundation" with 10 trials sponsored, "Spanish Breast Cancer Research Group" with 10 trials sponsored, "Spanish Lung Cancer Group" with 6 trials sponsored and "Boehringer Ingelheim" with 6 trials sponsored. Other sponsors include 56 different institutions and companies that sponsored additional 53 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Arnau de Vilanova" #1 collaborator was "Hoffmann-La Roche" with 6 trials as a collaborator, "Pfizer" with 4 trials as a collaborator, "AstraZeneca" with 3 trials as a collaborator, "Breast International Group" with 2 trials as a collaborator and "Bristol-Myers Squibb" with 2 trials as a collaborator. Other collaborators include 48 different institutions and companies that were collaborators in the rest 56 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Arnau de Vilanova" are "Breast Cancer" (13 trials), "Carcinoma, Non-Small-Cell Lung" (5 trials), "Lung Cancer" (5 trials), "Advanced Breast Cancer" (4 trials) and "Myelodysplastic Syndrome" (4 trials). Many other conditions were trialed in "Hospital Arnau de Vilanova" in a lesser frequency.

Most popular intervention types in "Hospital Arnau de Vilanova" are "Drug" (68 trials), "Other" (8 trials), "Biological" (4 trials), "Device" (4 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (5 trials), "Cyclophosphamide" (5 trials), "Docetaxel" (5 trials), "Paclitaxel" (5 trials) and "Placebo" (5 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Arnau de Vilanova" are 84 trials for "All" genders, 15 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital Arnau de Vilanova". undefined are not yet recruiting, 14 are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 61 completed trials in Hospital Arnau de Vilanova, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Arnau de Vilanova, 0 "Phase 1" clinical trials were conducted, 28 "Phase 2" clinical trials and 29 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 13 trials, and there were also 5 trials that are defined as “Not Applicable".